At Royds Withy King we are still able to serve all your legal needs during the Coronavirus pandemic. Find out more.

Search our news, events & opinions

On 1 September 2016 Withy King LLP merged with Royds LLP. The trading name for the merged firm is Royds Withy King. All content produced prior to this date will remain in the name of the firms pre-merger.

5 June 2014 0 Comments
Posted in Corporate & Commercial, Opinion

Fraud Office Investigate Leading Drug Company

Author headshot image Posted by , Partner

On Tuesday May 27th it was confirmed that the Serious Fraud Office had begun a formal criminal investigation into a leading drug company, GlaxoSmithKline, which is already facing claims of bribery in five other countries, including China.

Over recent weeks, there have been numerous reports that the drug company was facing investigations relating to bribery offences; whilst almost a fortnight ago, Chinese police confirmed that charges were being brought against several members of staff at the drug company.

Now, as was widely expected, the Serious Fraud Office has confirmed that it has launched a formal criminal investigation into the commercial practices of both the drug company and its subsidiaries; although neither the company nor Serious Fraud Office have confirmed further details in relation to the investigation.

With news that GlaxoSmithKline is facing further investigations in relation to their commercial practices; for those businesses which face allegations relating to bribery offences or fraud, our corporate and commercial solicitors will be able to assist.

To find out how we can help you, if you’re looking to start your own business, contact Claus Andersen or John North on 020 7583 2222.

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.

*required*

**required*

*optional*

Corporate & Commercial

Our corporate lawyers will get you the right deal and protect your business, now and in the future.

Learn more

Partner

T: 020 7842 1462 (DDI)
Email

Search our news, events & opinions